How should I evaluate and treat hyponatremia, considering symptom severity, serum sodium level, and volume status?

Evaluation and Treatment of Hyponatremia

Initial Assessment: Symptom Severity Determines Urgency

For severe symptomatic hyponatremia (seizures, coma, altered mental status, cardiorespiratory distress), immediately administer 3% hypertonic saline with a target correction of 6 mmol/L over 6 hours or until symptoms resolve—this is a medical emergency requiring ICU-level monitoring. 1, 2

Severe Symptoms (Immediate 3% Hypertonic Saline)

• Neurological emergencies: seizures, coma, obtundation, somnolence, or cardiorespiratory distress mandate immediate hypertonic saline 1, 2, 3
• Dosing: Give 100 mL boluses of 3% NaCl IV over 10 minutes, repeatable up to three times at 10-minute intervals 1
• Target: Increase sodium by 6 mmol/L in first 6 hours or until severe symptoms abate 1, 2
• Monitoring: Check serum sodium every 2 hours during initial correction 1

Moderate Symptoms (Hospitalization Required)

• Clinical features: nausea, vomiting, confusion, headache, weakness, or gait instability 4, 2
• Approach: Hospital admission with close monitoring; may require hypertonic saline if symptoms progress 1
• Monitoring: Serum sodium every 4-6 hours 1

Mild or Asymptomatic (Outpatient Management Possible)

• Clinical features: minimal or no symptoms, mild cognitive deficits 4, 2
• Approach: Treat underlying cause, implement fluid restriction or oral sodium supplementation based on etiology 1, 4

---

Critical Safety Limit: Never Exceed 8 mmol/L in 24 Hours

The absolute maximum sodium correction is 8 mmol/L in any 24-hour period to prevent osmotic demyelination syndrome (ODS)—this limit is non-negotiable regardless of symptom severity. 1, 5, 2

High-Risk Populations Requiring Slower Correction (4-6 mmol/L/day maximum)

• Advanced liver disease or cirrhosis 1, 2
• Chronic alcoholism 1, 2
• Malnutrition or prior hepatic encephalopathy 1
• Severe hyponatremia (<120 mmol/L) of chronic duration 1

Managing Overcorrection

• If sodium rises >8 mmol/L in 24 hours: Immediately stop hypertonic saline and administer D5W (5% dextrose in water) or desmopressin to relower sodium 1
• Goal: Bring total 24-hour correction back to ≤8 mmol/L from baseline 1

---

Volume Status Assessment: The Decisive Diagnostic Step

Accurate volume status assessment determines treatment strategy—hypovolemic patients need saline, euvolemic patients need fluid restriction, and hypervolemic patients need fluid restriction plus treatment of underlying disease. 1, 4, 5

Hypovolemic Hyponatremia (True Volume Depletion)

• Clinical signs: Orthostatic hypotension, tachycardia, dry mucous membranes, decreased skin turgor, flat neck veins 1, 5
• Laboratory: Urine sodium <30 mmol/L (extrarenal losses) or >20 mmol/L (renal losses) 1, 4
• Treatment: Isotonic saline (0.9% NaCl) at 15-20 mL/kg/h initially, then 4-14 mL/kg/h based on response 1
• Common causes: Diuretics, vomiting, diarrhea, third-spacing, burns 1, 4

Euvolemic Hyponatremia (SIADH Most Common)

• Clinical signs: No edema, no orthostatic hypotension, normal skin turgor, moist mucous membranes 1, 5
• Laboratory: Urine sodium >20-40 mmol/L, urine osmolality >300 mOsm/kg, serum uric acid <4 mg/dL 1, 4
• Treatment: Fluid restriction to 1 L/day as first-line; add oral sodium chloride 100 mEq three times daily if refractory 1, 4
• Common causes: Medications (SSRIs, carbamazepine, NSAIDs), malignancy, CNS disorders, pulmonary disease 1, 4, 6

Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)

• Clinical signs: Peripheral edema, ascites, jugular venous distention, pulmonary congestion 1, 5
• Laboratory: Urine sodium variable (often <20 mmol/L in cirrhosis, 50-70 mmol/L in heart failure) 1
• Treatment: Fluid restriction to 1-1.5 L/day for sodium <125 mmol/L; treat underlying disease 1, 4
• Cirrhosis-specific: Consider albumin infusion (8 g per liter of ascites removed); avoid hypertonic saline unless life-threatening symptoms 1

---

Diagnostic Workup: Essential Laboratory Tests

Order serum and urine osmolality, urine sodium, serum creatinine, TSH, and morning cortisol to determine etiology—do not delay treatment while awaiting results. 1, 4, 5

Initial Laboratory Panel

• Serum tests: Sodium, osmolality, glucose, creatinine, BUN, TSH, morning cortisol 1, 4
• Urine tests: Osmolality, sodium concentration 1, 4, 5
• Additional: Serum uric acid (<4 mg/dL suggests SIADH with 73-100% PPV) 1

Interpretation Algorithm

• Serum osmolality <275 mOsm/kg: Confirms hypotonic hyponatremia 1, 4
• Urine osmolality >100 mOsm/kg: Indicates impaired water excretion (SIADH, heart failure, cirrhosis) 1, 5
• Urine sodium <30 mmol/L: Predicts response to saline (71-100% PPV for hypovolemia) 1
• Urine sodium >20-40 mmol/L with high urine osmolality: Suggests SIADH 1, 4

Tests NOT Recommended

• Plasma ADH levels: Not supported by evidence; delays diagnosis without changing management 1
• Natriuretic peptide levels: Not useful for routine hyponatremia evaluation 1

---

Treatment by Etiology and Volume Status

SIADH (Euvolemic)

• First-line: Fluid restriction to 1 L/day 1, 4, 6
• Second-line: Oral sodium chloride 100 mEq three times daily if fluid restriction fails 1
• Pharmacologic options: Urea, demeclocycline, lithium, loop diuretics (for resistant cases) 1, 6
• Vaptans: Tolvaptan 15 mg daily (titrate to 30-60 mg) for refractory euvolemic or hypervolemic hyponatremia; use with caution due to risk of overcorrection 1, 2, 6

Hypovolemic Hyponatremia

• Treatment: Isotonic saline (0.9% NaCl) for volume repletion 1, 4
• Discontinue diuretics if sodium <125 mmol/L 1
• Correction rate: Standard 4-8 mmol/L per day, maximum 8 mmol/L in 24 hours 1

Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)

• Fluid restriction: 1-1.5 L/day for sodium <125 mmol/L 1, 4
• Discontinue diuretics temporarily if sodium <125 mmol/L 1
• Cirrhosis-specific: Albumin infusion; avoid hypertonic saline unless life-threatening symptoms 1
• Heart failure: Optimize guideline-directed medical therapy (ACE inhibitors, beta-blockers) before adding vaptans 1

---

Special Populations and Pitfalls

Neurosurgical Patients: Distinguish SIADH from Cerebral Salt Wasting (CSW)

• SIADH: Euvolemic, CVP 6-10 cm H₂O; treat with fluid restriction 1
• CSW: Hypovolemic, CVP <6 cm H₂O, orthostatic hypotension; treat with volume and sodium replacement (isotonic or hypertonic saline) 1
• Critical error: Fluid restriction in CSW worsens outcomes and can be fatal 1
• Subarachnoid hemorrhage: Never use fluid restriction; consider fludrocortisone 0.1-0.2 mg daily to prevent vasospasm 1

Cirrhotic Patients

• Correction rate: Maximum 4-6 mmol/L per day (absolute ceiling 8 mmol/L in 24 hours) due to exceptionally high ODS risk 1
• Hyponatremia in cirrhosis: Reflects worsening hemodynamic status; sodium ≤130 mmol/L increases risk of spontaneous bacterial peritonitis (OR 3.40), hepatorenal syndrome (OR 3.45), and hepatic encephalopathy (OR 2.36) 1
• Tolvaptan caution: Higher risk of GI bleeding (10% vs 2% placebo) and hepatotoxicity in cirrhosis 1

Chronic Alcoholism and Malnutrition

• Beer potomania: Discontinue alcohol; provide thiamine 500 mg IV three times daily before any glucose-containing fluids to prevent Wernicke's encephalopathy 1
• Correction rate: Maximum 4-6 mmol/L per day due to high ODS risk 1

---

Common Pitfalls to Avoid

• Ignoring mild hyponatremia (130-135 mmol/L): Even mild hyponatremia increases fall risk (21% vs 5%) and mortality (60-fold increase if <130 mmol/L) 1, 2
• Overly rapid correction: Exceeding 8 mmol/L in 24 hours causes osmotic demyelination syndrome (dysarthria, dysphagia, oculomotor dysfunction, quadriparesis 2-7 days post-correction) 1, 5, 2
• Using fluid restriction in CSW: Worsens hypovolemia and cerebral ischemia 1
• Using hypertonic saline in hypervolemic hyponatremia without severe symptoms: Worsens edema and ascites 1
• Inadequate monitoring during active correction: Check sodium every 2 hours for severe symptoms, every 4 hours after symptom resolution 1
• Failing to treat underlying cause: Identify and address medications, malignancy, CNS disorders, or endocrine abnormalities 1, 4

---

Monitoring Protocol

Severe Symptomatic Hyponatremia

• Serum sodium: Every 2 hours during initial correction 1
• After symptom resolution: Every 4 hours 1
• ICU admission: Required for close monitoring and hypertonic saline administration 1

Moderate Symptomatic or Asymptomatic

• Serum sodium: Every 4-6 hours initially, then daily once stable 1
• Electrolytes: Monitor potassium, magnesium, chloride concurrently 1

Watch for Osmotic Demyelination Syndrome

• Timing: Typically 2-7 days after rapid correction 1
• Signs: Dysarthria, dysphagia, oculomotor dysfunction, quadriparesis, altered mental status 1

---

Transition from Acute to Chronic Management

Once severe symptoms resolve and sodium reaches 120-125 mmol/L, discontinue 3% hypertonic saline and transition to isotonic maintenance fluids (0.9% NaCl) or fluid restriction based on volume status. 1, 7

• Avoid hypotonic fluids (0.45% saline, lactated Ringer's, D5W) as they can worsen hyponatremia 1, 4
• Continue monitoring to ensure total 24-hour correction does not exceed 8 mmol/L 1, 7
• Implement etiology-specific therapy: Fluid restriction for SIADH, volume repletion for hypovolemia, treat underlying disease for hypervolemia 1, 4